Europe’s health sector worried about post-Brexit investment dearth

By |oktober 1st, 2018|biotech, Innovation, News, pharmaceuticals, research|

Fragmented, multilingual and over-regulated: Europe is currently not an attractive place for investors and things could get worse after Brexit, experts from the life sciences industry have warned.

Komentarji so izklopljeni za Europe’s health sector worried about post-Brexit investment dearth

UK biotech boasts Europe’s best pipeline as Brexit looms

By |maj 24th, 2017|BioIndustry Association, biotech, Brexit, drugs, immigration, News, UK|

Britain's biotech sector boasts the strongest new drug pipeline in Europe but industry leaders say it needs continued access to global talent, funding and regulatory clarity to thrive in the future - all of which could be jeopardised by Brexit.

Komentarji so izklopljeni za UK biotech boasts Europe’s best pipeline as Brexit looms